DD224319A5 - Verfahren zur herstellung von 4-oxo-thiazolidin-2-yliden-acetamidderivaten - Google Patents

Verfahren zur herstellung von 4-oxo-thiazolidin-2-yliden-acetamidderivaten Download PDF

Info

Publication number
DD224319A5
DD224319A5 DD84262809A DD26280984A DD224319A5 DD 224319 A5 DD224319 A5 DD 224319A5 DD 84262809 A DD84262809 A DD 84262809A DD 26280984 A DD26280984 A DD 26280984A DD 224319 A5 DD224319 A5 DD 224319A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
carbon atoms
group
ylidene
hydrogen atom
Prior art date
Application number
DD84262809A
Other languages
German (de)
English (en)
Inventor
Gerhard Satzinger
Johannes Hartenstein
Manfred Herrmann
Gerd Bartoszyk
Edgar Fritschi
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of DD224319A5 publication Critical patent/DD224319A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
DD84262809A 1983-05-10 1984-05-08 Verfahren zur herstellung von 4-oxo-thiazolidin-2-yliden-acetamidderivaten DD224319A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3317000A DE3317000C2 (de) 1983-05-10 1983-05-10 4-Oxo-thiazolidin-2-yliden-acetamid-derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung von durch das Zentralnervensystem bedingten Konvulsionen

Publications (1)

Publication Number Publication Date
DD224319A5 true DD224319A5 (de) 1985-07-03

Family

ID=6198604

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84262809A DD224319A5 (de) 1983-05-10 1984-05-08 Verfahren zur herstellung von 4-oxo-thiazolidin-2-yliden-acetamidderivaten

Country Status (19)

Country Link
US (1) US4563471A (ru)
EP (1) EP0124911B1 (ru)
JP (1) JPS59206372A (ru)
AT (1) ATE65778T1 (ru)
AU (1) AU565799B2 (ru)
BG (2) BG40143A3 (ru)
CA (1) CA1237436A (ru)
CS (1) CS244814B2 (ru)
DD (1) DD224319A5 (ru)
DE (2) DE3317000C2 (ru)
DK (1) DK162048C (ru)
ES (2) ES8502430A1 (ru)
GR (1) GR82086B (ru)
HU (1) HU190566B (ru)
IE (1) IE57372B1 (ru)
PL (2) PL142398B1 (ru)
SU (2) SU1251803A3 (ru)
YU (2) YU45183B (ru)
ZA (1) ZA843489B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269024A3 (en) * 1986-11-21 1990-05-09 Godecke Aktiengesellschaft Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
KR100329808B1 (ko) * 2000-01-14 2002-03-25 박호군 2-펜아실리덴-3,5-알킬치환된-1,3-티아졸리딘-4-온의 효율적 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1150985B (de) * 1961-03-06 1963-07-04 Warner Lambert Pharmaceutical Verfahren zur Herstellung von Thiazolidin-4-on-Derivaten
FR2726M (fr) * 1962-12-04 1964-08-17 Warner Lambert Pharmaceutical Amides de thiazolidinones substituées.
DE2423725C2 (de) * 1974-05-16 1982-12-30 Gödecke AG, 1000 Berlin 5-Phenyl-4-oxo-Delta 2,ALPHA-thiazolidinessigsäureester

Also Published As

Publication number Publication date
SU1272985A3 (ru) 1986-11-23
SU1251803A3 (ru) 1986-08-15
DK162048B (da) 1991-09-09
ATE65778T1 (de) 1991-08-15
BG41129A3 (en) 1987-04-15
PL142398B1 (en) 1987-10-31
DE3317000A1 (de) 1984-11-15
EP0124911A3 (en) 1987-02-04
DE3484859D1 (de) 1991-09-05
AU565799B2 (en) 1987-10-01
BG40143A3 (en) 1986-10-15
ES532322A0 (es) 1985-01-01
ES8502430A1 (es) 1985-01-01
PL247581A1 (en) 1985-07-16
YU45183B (en) 1992-05-28
DK162048C (da) 1992-02-10
IE841150L (en) 1984-11-10
HUT34174A (en) 1985-02-28
PL142365B1 (en) 1987-10-31
JPS59206372A (ja) 1984-11-22
AU2788984A (en) 1984-11-15
DE3317000C2 (de) 1986-09-25
US4563471A (en) 1986-01-07
ES532331A0 (es) 1985-01-16
DK229984A (da) 1984-11-11
JPS6316386B2 (ru) 1988-04-08
HU190566B (en) 1986-09-29
YU63586A (en) 1986-10-31
IE57372B1 (en) 1992-08-12
CA1237436A (en) 1988-05-31
ZA843489B (en) 1984-12-24
EP0124911B1 (de) 1991-07-31
EP0124911A2 (de) 1984-11-14
DK229984D0 (da) 1984-05-09
CS244814B2 (en) 1986-08-14
ES8502696A1 (es) 1985-01-16
YU79284A (ru) 1986-10-31
GR82086B (ru) 1984-12-13
PL252100A1 (en) 1985-11-05

Similar Documents

Publication Publication Date Title
DE69629390T2 (de) Indandimerverbindungen mit relaxierender wirkung auf die glatten muskeln und/oder mit mastzellen stabilisiernder und/oder entzuendungshemmender wirkung
DE3031791C2 (ru)
DE1620035A1 (de) 3-Amino-5-X-6-halogenpyrazinonitrile und Verfahren zu deren Herstellung
DD224319A5 (de) Verfahren zur herstellung von 4-oxo-thiazolidin-2-yliden-acetamidderivaten
DE2356903A1 (de) Verfahren zur herstellung substituierter chromon-3-carbonitrile, -carboxamide und -carbonsaeuren
DE2023000C2 (de) Neue 5-Cycloalkyl-1-indancarbonsäuren, 6-Cycloalkyltetralin-1-carbonsäuren, Derivate davon und Verfahren zu ihrer Herstellung
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
DE2240664A1 (de) Thiolester von guanidin-substituierten carbonsaeuren
DE2723051A1 (de) N-(acyl)-p-amino-n'-(monosubstit.)- benzamide sowie diese enthaltende arzneimittel
DE2535147A1 (de) 2-thiol-4,5-diphenyloxazol-s-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH616650A5 (ru)
DE2640616C3 (de) Verfahren zur Herstellung von N-Acyl-2-aiylglycinen
DE2415691A1 (de) Substituierte benzamide, verfahren zu deren herstellung und deren verwendung
CH634835A5 (de) Verfahren zur herstellung von neuen benzodiazepinderivaten.
AT372940B (de) Verfahren zur herstellung von (d)-(-)-phydroxyphenylglycylchlorid-hydrochlorid
AT362353B (de) Verfahren zur herstellung von neuen in 4- -stellung substituierten 3-sulfamoyl-5-pyrrolyl - oder -5-pyrrolylalkylbenzoesaeuren und ihren salzen
DE1695722C3 (de) i-Acyl-3-lndolylcarbonsäurederivate und Verfahren zu ihrer Herstellung
AT328458B (de) Verfahren zur herstellung neuer diazepinderivate sowie deren 5-oxide und saureadditionssalze
DE1543942C (de) Verfahren zur Herstellung von 1 Oxa 2 methyl 3 carbonylarmno 4 tnia cyclohe xen(2)en
CH623317A5 (en) Process for the preparation of benzamides
EP0150411A1 (de) Verfahren zur Herstellung substituierter Chinazolin-2.4(1H.3H)-dione
AT226710B (de) Verfahren zur Herstellung von neuen Dihydrochinoxalonen-(2) und von deren Salzen
AT375650B (de) Verfahren zur herstellung von neuen 4-hydroxy-2 -benzimidazolinon-derivaten und von deren salzen, razematen und optisch aktiven formen
AT308754B (de) Verfahren zur Herstellung von Benzodiazepinderivaten und von Säureadditionssalzen hievon
DE1668351A1 (de) alpha-Hydroxy-ss-aralkylcarbon-saeureamide und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee